Journal article 1177 views
Targeted radionuclide therapy in combined-modality regimens
The Lancet Oncology, Volume: 18, Issue: 7, Pages: e414 - e423
Swansea University Author:
Martin Gill
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1016/s1470-2045(17)30379-0
Abstract
Targeted radionuclide therapy in combined-modality regimens
| Published in: | The Lancet Oncology |
|---|---|
| ISSN: | 1470-2045 |
| Published: |
Elsevier BV
2017
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa52927 |
| first_indexed |
2019-12-03T13:15:01Z |
|---|---|
| last_indexed |
2020-10-20T03:03:57Z |
| id |
cronfa52927 |
| recordtype |
SURis |
| fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2020-10-19T14:55:43.9210415</datestamp><bib-version>v2</bib-version><id>52927</id><entry>2019-12-02</entry><title>Targeted radionuclide therapy in combined-modality regimens</title><swanseaauthors><author><sid>485d85b532851e8863cd19c6af7e00f7</sid><ORCID>0000-0002-1371-5676</ORCID><firstname>Martin</firstname><surname>Gill</surname><name>Martin Gill</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2019-12-02</date><deptcode>EAAS</deptcode><abstract/><type>Journal Article</type><journal>The Lancet Oncology</journal><volume>18</volume><journalNumber>7</journalNumber><paginationStart>e414</paginationStart><paginationEnd>e423</paginationEnd><publisher>Elsevier BV</publisher><issnPrint>1470-2045</issnPrint><keywords/><publishedDay>1</publishedDay><publishedMonth>7</publishedMonth><publishedYear>2017</publishedYear><publishedDate>2017-07-01</publishedDate><doi>10.1016/s1470-2045(17)30379-0</doi><url/><notes/><college>COLLEGE NANME</college><department>Engineering and Applied Sciences School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>EAAS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2020-10-19T14:55:43.9210415</lastEdited><Created>2019-12-02T15:55:16.9657642</Created><path><level id="1">Faculty of Science and Engineering</level><level id="2">School of Engineering and Applied Sciences - Chemistry</level></path><authors><author><firstname>Martin</firstname><surname>Gill</surname><orcid>0000-0002-1371-5676</orcid><order>1</order></author><author><firstname>Nadia</firstname><surname>Falzone</surname><order>2</order></author><author><firstname>Yong</firstname><surname>Du</surname><order>3</order></author><author><firstname>Katherine A</firstname><surname>Vallis</surname><order>4</order></author></authors><documents/><OutputDurs/></rfc1807> |
| spelling |
2020-10-19T14:55:43.9210415 v2 52927 2019-12-02 Targeted radionuclide therapy in combined-modality regimens 485d85b532851e8863cd19c6af7e00f7 0000-0002-1371-5676 Martin Gill Martin Gill true false 2019-12-02 EAAS Journal Article The Lancet Oncology 18 7 e414 e423 Elsevier BV 1470-2045 1 7 2017 2017-07-01 10.1016/s1470-2045(17)30379-0 COLLEGE NANME Engineering and Applied Sciences School COLLEGE CODE EAAS Swansea University 2020-10-19T14:55:43.9210415 2019-12-02T15:55:16.9657642 Faculty of Science and Engineering School of Engineering and Applied Sciences - Chemistry Martin Gill 0000-0002-1371-5676 1 Nadia Falzone 2 Yong Du 3 Katherine A Vallis 4 |
| title |
Targeted radionuclide therapy in combined-modality regimens |
| spellingShingle |
Targeted radionuclide therapy in combined-modality regimens Martin Gill |
| title_short |
Targeted radionuclide therapy in combined-modality regimens |
| title_full |
Targeted radionuclide therapy in combined-modality regimens |
| title_fullStr |
Targeted radionuclide therapy in combined-modality regimens |
| title_full_unstemmed |
Targeted radionuclide therapy in combined-modality regimens |
| title_sort |
Targeted radionuclide therapy in combined-modality regimens |
| author_id_str_mv |
485d85b532851e8863cd19c6af7e00f7 |
| author_id_fullname_str_mv |
485d85b532851e8863cd19c6af7e00f7_***_Martin Gill |
| author |
Martin Gill |
| author2 |
Martin Gill Nadia Falzone Yong Du Katherine A Vallis |
| format |
Journal article |
| container_title |
The Lancet Oncology |
| container_volume |
18 |
| container_issue |
7 |
| container_start_page |
e414 |
| publishDate |
2017 |
| institution |
Swansea University |
| issn |
1470-2045 |
| doi_str_mv |
10.1016/s1470-2045(17)30379-0 |
| publisher |
Elsevier BV |
| college_str |
Faculty of Science and Engineering |
| hierarchytype |
|
| hierarchy_top_id |
facultyofscienceandengineering |
| hierarchy_top_title |
Faculty of Science and Engineering |
| hierarchy_parent_id |
facultyofscienceandengineering |
| hierarchy_parent_title |
Faculty of Science and Engineering |
| department_str |
School of Engineering and Applied Sciences - Chemistry{{{_:::_}}}Faculty of Science and Engineering{{{_:::_}}}School of Engineering and Applied Sciences - Chemistry |
| document_store_str |
0 |
| active_str |
0 |
| published_date |
2017-07-01T11:14:16Z |
| _version_ |
1851029042683183104 |
| score |
11.089677 |

